Cognex Corporation (CGNX) News
Filter CGNX News Items
CGNX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CGNX News Highlights
- For CGNX, its 30 day story count is now at 64.
- Over the past 23 days, the trend for CGNX's stories per day has been choppy and unclear. It has oscillated between 1 and 25.
- The most mentioned tickers in articles about CGNX are BEAT, AG and ABUS.
Latest CGNX News From Around the Web
Below are the latest news stories about Cognex Corp that investors may wish to consider to help them evaluate CGNX as an investment opportunity.
1 Undervalued Growth Stock That Could Soar in 2022The stock of machine-vision company Cognex (NASDAQ: CGNX) has been severely beaten up in the sell-off of technology stocks in 2022. Cognex's revenue and margin performance beat management's prior expectations in the fourth quarter. The results confirmed Cognex has plenty of potential within its end markets in 2022, including electric vehicle (EV) and logistics spending. |
Declining Stock and Solid Fundamentals: Is The Market Wrong About Cognex Corporation (NASDAQ:CGNX)?Cognex (NASDAQ:CGNX) has had a rough three months with its share price down 18%. However, stock prices are usually... |
Cognex Corporation (CGNX) CEO Rob Willett on Q4 2021 Results - Earnings Call TranscriptCognex Corporation (CGNX) Q4 2021 Earnings Conference Call February 17, 2022, 05:00 PM ET Company Participants Susan Conway - Senior Director, IR Rob Willett - President and CEO Paul Todgham - CFO Conference Call Participants Josh Pokrzywinski - Morgan Stanley Jacob Levinson - Melius Research Michael Anastasiou - Cowen and... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning! |
Why Cognex Shares Rose Nearly 6% TodayThe machine vision company pleased investors with an excellent earnings report. |
Cognex Soars After Q4 Beat, Annual Revenue Tops $1 Billion By Investing.comCognex Soars After Q4 Beat, Annual Revenue Tops $1 Billion |
Here''s Why Cognex Shares Are Trading Higher PremarketJPMorgan analyst Paul Chung upgraded Cognex Corp (NASDAQ: CGNX ) to Neutral from Underweight with a price target of $68, down from $80, post the Q4 beat. The price target implies an upside of 10.3%. Cognex''s Q4 FY21 revenue of $244.1 million beat the consensus of $222.96 million. EPS of $0.30 beat the consensus of $0.22. Cognex sees Q1 FY22 revenue of … Full story available on Benzinga.com |
Thinking about buying stock in Cognex Corp, Bloomin'' Brands, Livent Corp, Sandstorm Gold, or Arbutus Biopharma?NEW YORK , Feb. 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CGNX, BLMN, LTHM, SAND, and ABUS. … Full story available on Benzinga.com |
Here's Why Cognex Shares Are Trading Higher PremarketJPMorgan analyst Paul Chung upgraded Cognex Corp (NASDAQ: CGNX) to Neutral from Underweight with a price target of $68, down from $80, post the Q4 beat. The price target implies an upside of 10.3%. Cognex's Q4 FY21 revenue of $244.1 million beat the consensus of $222.96 million. EPS of $0.30 beat the consensus of $0.22. Cognex sees Q1 FY22 revenue of $265 million - $285 million, above the consensus of $249.9 million. See: Cognex's Q4 Earnings The valuation multiple on enterprise value to EBITDA |
Cognex Soars After Q4 Beat, Annual Revenue Tops $1 BillionBy Dhirendra Tripathi |